People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| OG DNA Genetics Inc. | — | Other | Series B | $35.6M | $398.6M | 2018 |
| TranspareRx Corp | — | Other Health Care | Seed | $6.9M | $20.3M | 2023 |
| Valisure Enterprises Inc. | — | Other Health Care | Series A | $4.0M | $22.3M | 2024 |
Charles Phillips at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Phillips on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Cunningham | 1 | 4 |
| Michael Sims | 1 | 4 |
| Michael Lowe | 1 | 4 |
| Marcus Osborne | 1 | 2 |
| Wolfgang Hinz | 1 | 2 |
| Kaury Kucera | 1 | 2 |
| David Light | 1 | 2 |
| Adam Clark-Joseph | 1 | 2 |
| David Harrell | 1 | 2 |
| Donald Morris | 1 | 2 |
| Neil Bajaj | 1 | 1 |
| Thomas Gibbons | 1 | 1 |
| Karthik Sundaram | 1 | 1 |
| Rezwan Aaron Khan | 1 | 1 |
| Israel Aaron Yarkoni | 1 | 1 |
| Donald Wayne Morris | 1 | 1 |
| Joshua Aaron Hamlin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.